Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Feb-21 4:54 PM View:  | Motus Gi Holdings, Inc. (MOTS) | 26-Jan-21 | Market Sale | 59,115 | $1.90 | $112,417.00 | (2%) 3.81M to 3.75M | 42% |
| 10-Jun-20 5:05 PM View: | Biolase Technology, Inc. (BIOL) | 09-Jun-20 | Market Sale | 1,770,310 | $0.55 | $976,010.00 | (30%) 5.98M to 4.21M | (9%) |
| 10-Jun-20 5:03 PM View: | Vermillion, Inc. (AWH) | 08-Jun-20 | Exercise (in-the money or at-the-money) | 463,298 | $1.80 | $833,936.00 | 5% 9.83M to 10.29M | |
| 10-Jun-20 5:05 PM View: | Biolase Technology, Inc. (BIOL) | 08-Jun-20 | Market Sale | 3,402,940 | $0.55 | $1,885,910.00 | (36%) 9.39M to 5.98M | (8%) |
| 09-Jun-20 5:16 PM View: | Soleno Therapeutics Inc (SLNO) | 08-Jun-20 | Market Sale | 150,918 | $3.40 | $513,302.00 | (3%) 4.63M to 4.48M | 44% |
| 09-Jun-20 5:16 PM View: | Soleno Therapeutics Inc (SLNO) | 05-Jun-20 | Market Sale | 49,325 | $3.34 | $164,578.00 | (1%) 4.68M to 4.63M | 43% |
| 31-Oct-19 9:21 PM View: | Biolase Technology, Inc. (BIOL) | 29-Oct-19 | Purchase | 17,391 | $57.50 | $999,982.00 | 100% 0 to 17.39K | |
| 30-Jul-19 4:30 PM View: | Soleno Therapeutics Inc (SLNO) | 26-Jul-19 | Market Purchase | 57,069 | $2.14 | $122,276.00 | 1% 3.81M to 3.87M | (11%) |
| 01-Jul-19 5:24 PM View: | Motus Gi Holdings, Inc. (MOTS) | 01-Jul-19 | Market Purchase | 40,000 | $3.01 | $120,501.00 | 1% 3.89M to 3.93M | (65%) |
| 01-Jul-19 5:24 PM View: | Motus Gi Holdings, Inc. (MOTS) | 27-Jun-19 | Market Purchase | 991,666 | $3.00 | $2,975,000.00 | 34% 2.9M to 3.89M | (65%) |
| 27-Jun-19 4:31 PM View: | Biolase Technology, Inc. (BIOL) | 25-Jun-19 | Market Sale | 1,000,000 | $1.50 | $1,500,000.00 | (16%) 6.17M to 5.17M | 61% |
| 18-Mar-19 6:25 PM View: | Soleno Therapeutics Inc (SLNO) | 14-Mar-19 | Market Purchase | 130,363 | $1.22 | $159,392.00 | 2% 6.2M to 6.33M | 55% |
| 21-Dec-18 4:16 PM View: | Soleno Therapeutics Inc (SLNO) | 19-Dec-18 | Market Purchase | 1,245,140 | $1.61 | $2,000,060.00 | 51% 2.44M to 3.68M | 15% |
| 16-May-18 4:30 PM View: | Soleno Therapeutics Inc (SLNO) | 15-May-18 | Market Purchase | 1,474 | $1.93 | $2,841.28 | < 1% 2.44M to 2.44M | (4%) |
| 16-May-18 4:30 PM View: | Soleno Therapeutics Inc (SLNO) | 14-May-18 | Market Purchase | 48,526 | $1.79 | $86,939.20 | 2% 2.39M to 2.44M | 3% |
| 06-Dec-17 4:33 PM View: | Biolase Technology, Inc. (BIOL) | 05-Dec-17 | Market Purchase | 10,745,600 | $0.46 | $4,900,000.00 | 53% 20.12M to 30.87M | (71%) |
| 06-Dec-17 4:33 PM View: | Biolase Technology, Inc. (BIOL) | 04-Dec-17 | Private Purchase | 1,800,000 | $0.30 | $540,000.00 | 10% 18.32M to 20.12M | |
| 31-Aug-17 7:43 PM View: | Vermillion, Inc. (AWH) | 31-Aug-17 | Exercise (in-the money or at-the-money) | 583,333 | $1.00 | $583,333.00 | 6% 9.24M to 9.83M | |
| 05-Jul-17 4:19 PM View: | Biolase Technology, Inc. (BIOL) | 30-Jun-17 | Conversion | 3,698,600 | $1.24 | $4,586,260.00 | 25% 14.62M to 18.32M | (22%) |
| 17-Feb-17 5:10 PM View: | Vermillion, Inc. (AWH) | 17-Feb-17 | Private Purchase | 617,731 | $1.40 | $864,823.00 | 7% 9.21M to 9.83M | |
| 06-Dec-16 6:31 PM View: | Biolase Technology, Inc. (BIOL) | 05-Dec-16 | Conversion | 46,463 | $1.85 | $85,956.60 | < 1% 29.12M to 29.17M | (93%) |
| 06-Dec-16 6:31 PM View: | Biolase Technology, Inc. (BIOL) | 02-Dec-16 | Conversion | 53,537 | $1.78 | $95,295.90 | < 1% 29.07M to 29.12M | (93%) |
| 17-Nov-16 3:37 PM View: | Biolase Technology, Inc. (BIOL) | 16-Nov-16 | Conversion | 33,674 | $1.71 | $57,582.50 | < 1% 28.95M to 28.99M | (92%) |
| 17-Nov-16 3:37 PM View: | Biolase Technology, Inc. (BIOL) | 15-Nov-16 | Conversion | 18,514 | $1.72 | $31,844.10 | < 1% 28.93M to 28.95M | (92%) |
| 14-Nov-16 6:42 PM View: | Biolase Technology, Inc. (BIOL) | 14-Nov-16 | Conversion | 33,674 | $1.61 | $54,215.10 | < 1% 43.23M to 43.26M | (92%) |
| 14-Nov-16 6:42 PM View: | Biolase Technology, Inc. (BIOL) | 11-Nov-16 | Conversion | 48,513 | $1.81 | $87,808.50 | < 1% 43.18M to 43.23M | (93%) |
| 14-Nov-16 6:42 PM View: | Biolase Technology, Inc. (BIOL) | 10-Nov-16 | Conversion | 42,000 | $1.81 | $76,020.00 | < 1% 43.14M to 43.18M | (93%) |
| 10-Nov-16 6:01 PM View: | Biolase Technology, Inc. (BIOL) | 09-Nov-16 | Conversion | 125,000 | $1.70 | $212,500.00 | < 1% 14.21M to 14.34M | (92%) |
| 10-Nov-16 6:01 PM View: | Biolase Technology, Inc. (BIOL) | 08-Nov-16 | Conversion | 2,000 | $1.52 | $3,040.00 | < 1% 14.23M to 14.23M | (91%) |
| 05-Oct-16 5:21 PM View: | Biolase Technology, Inc. (BIOL) | 30-Sep-16 | Conversion Duplicate | 3,699,100 | $1.13 | $4,179,980.00 | 35% 10.53M to 14.23M | 3% |
| 29-Jul-16 11:08 AM View: | Hansen Medical, Inc. (HNSN) | 27-Jul-16 | Disposition | 4,483,610 | $9,390,970.00 | $42,105,497,976,832.00 | (100%) 4.48M to 0 | |
| 09-Feb-16 6:51 PM View: | Accelerate Diagnostics, Inc. (AXDX) | 09-Feb-16 | Market Sale | 40,000 | $11.86 | $474,400.00 | (< 1%) 5.64M to 5.6M | 12% |
| 09-Feb-16 6:51 PM View: | Accelerate Diagnostics, Inc. (AXDX) | 09-Feb-16 | Market Sale | 560,000 | $11.86 | $6,641,600.00 | (10%) 5.6M to 5.04M | 12% |
| 22-Dec-15 4:17 PM View: | Accelerate Diagnostics, Inc. (AXDX) | 18-Dec-15 | Exercise (in-the money or at-the-money) | 100,000 | $17.50 | $1,750,000.00 | 2% 5.54M to 5.64M | |
| 10-Dec-15 4:14 PM View: | Accelerate Diagnostics, Inc. (AXDX) | 10-Dec-15 | Private Purchase | 58,824 | $17.00 | $1,000,010.00 | 1% 5.52M to 5.58M | 21% |
| 10-Dec-15 4:14 PM View: | Accelerate Diagnostics, Inc. (AXDX) | 10-Dec-15 | Private Purchase | 58,823 | $17.00 | $999,991.00 | 1% 5.58M to 5.64M | 21% |
| 12-Nov-15 5:01 PM View: | Biolase Technology, Inc. (BIOL) | 11-Nov-15 | Market Purchase | 54,800 | $0.79 | $43,478.30 | < 1% 10.47M to 10.53M | (83%) |
| 16-Jul-15 9:19 PM View: | Vermillion, Inc. (AWH) | 14-Jul-15 | Market Purchase | 512,043 | $1.96 | $1,003,500.00 | 6% 8.11M to 8.62M | |
| 14-May-15 9:42 PM View: | Hansen Medical, Inc. (HNSN) | 12-May-15 | Private Purchase | 18,888,700 | $0.65 | $12,277,600.00 | 73% 25.95M to 44.83M | |
| 29-Dec-14 2:36 PM View: | Vermillion, Inc. (AWH) | 23-Dec-14 | Market Purchase | 972,222 | $1.44 | $1,400,000.00 | 14% 7.14M to 8.11M | |
| 06-Nov-14 4:18 PM View: | Biolase Technology, Inc. (BIOL) | 03-Nov-14 | Market Purchase | 2,067,980 | $2.39 | $4,942,470.00 | 25% 8.41M to 10.47M | (94%) |
| 25-Aug-14 5:54 PM View: | Hansen Medical, Inc. (HNSN) | 25-Aug-14 | Exercise (in-the money or at-the-money) | 6,481,440 | $1.13 | $7,324,030.00 | 33% 19.46M to 25.95M | (65%) |
| 07-Aug-14 5:27 PM View: | Accelerate Diagnostics, Inc. (AXDX) | 05-Aug-14 | Market Purchase | 11,835 | $15.92 | $188,413.00 | < 1% 5.41M to 5.42M | (35%) |
| 22-Jul-14 9:26 PM View: | Biolase Technology, Inc. (BIOL) | 18-Jul-14 | Market Purchase | 2,270,840 | $1.92 | $4,360,000.00 | 37% 6.14M to 8.41M | (93%) |
| 16-Jul-14 7:07 PM View: | Accelerate Diagnostics, Inc. (AXDX) | 16-Jul-14 | Market Purchase | 10,000 | $19.96 | $199,600.00 | < 1% 5.4M to 5.41M | (48%) |
| 16-Jul-14 7:07 PM View: | Accelerate Diagnostics, Inc. (AXDX) | 14-Jul-14 | Market Purchase | 10,000 | $23.12 | $231,200.00 | < 1% 5.39M to 5.4M | (55%) |
| 01-Jul-14 3:23 PM View: | Accelerate Diagnostics, Inc. (AXDX) | 30-Jun-14 | Market Purchase | 20,000 | $25.72 | $514,400.00 | < 1% 5.37M to 5.39M | (59%) |
| 14-May-14 4:32 PM View: | Accelerate Diagnostics, Inc. (AXDX) | 12-May-14 | Market Purchase | 297,618 | $16.80 | $4,999,980.00 | 6% 5.08M to 5.38M | (38%) |
| 29-Apr-14 4:31 PM View: | Accelerate Diagnostics, Inc. (AXDX) | 28-Apr-14 | Exercise (in-the money or at-the-money) | 303,842 | $16.80 | $5,104,550.00 | 6% 4.77M to 5.08M | (38%) |
| 29-Apr-14 4:31 PM View: | Accelerate Diagnostics, Inc. (AXDX) | 28-Apr-14 | Exercise (in-the money or at-the-money) | 1,278 | $16.80 | $21,470.40 | < 1% 5.08M to 5.08M | (38%) |